by Co-Diagnostics | Apr 20, 2020 | Market Update
Salt Lake City, Utah – April 20, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that Company COVID-19 test sales in the United States have continued...
by Co-Diagnostics | Apr 16, 2020 | News Release
Salt Lake City, Utah – April 16, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX) (the Company), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that OralDNA® Labs, a CLIA-certified laboratory, has...
by Co-Diagnostics | Apr 14, 2020 | News Release
Salt Lake City, Utah – April 14, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX) (the Company), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that it has contracted with Madison, Wisconsin-based...
by Co-Diagnostics | Apr 6, 2020 | News Release
Salt Lake City, Utah – April 6, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that its Logix Smart™ Coronavirus COVID-19 Test has obtained Emergency...
